167 related articles for article (PubMed ID: 17623671)
61. Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients.
Oliveira-Ferrer L; Goswami R; Galatenko V; Ding Y; Eylmann K; Legler K; Kürti S; Schmalfeldt B; Milde-Langosch K
Dis Markers; 2018; 2018():6714287. PubMed ID: 30050594
[TBL] [Abstract][Full Text] [Related]
62. Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer.
Ieda J; Yokoyama S; Tamura K; Takifuji K; Hotta T; Matsuda K; Oku Y; Nasu T; Kiriyama S; Yamamoto N; Nakamura Y; Shively JE; Yamaue H
Int J Cancer; 2011 Sep; 129(6):1351-61. PubMed ID: 21413011
[TBL] [Abstract][Full Text] [Related]
63. Shc and CEACAM1 interact to regulate the mitogenic action of insulin.
Poy MN; Ruch RJ; Fernstrom MA; Okabayashi Y; Najjar SM
J Biol Chem; 2002 Jan; 277(2):1076-84. PubMed ID: 11694516
[TBL] [Abstract][Full Text] [Related]
64. CEACAM1 (CD66a) promotes human monocyte survival via a phosphatidylinositol 3-kinase- and AKT-dependent pathway.
Yu Q; Chow EM; Wong H; Gu J; Mandelboim O; Gray-Owen SD; Ostrowski MA
J Biol Chem; 2006 Dec; 281(51):39179-93. PubMed ID: 17071610
[TBL] [Abstract][Full Text] [Related]
65. Dapper1 is a nucleocytoplasmic shuttling protein that negatively modulates Wnt signaling in the nucleus.
Gao X; Wen J; Zhang L; Li X; Ning Y; Meng A; Chen YG
J Biol Chem; 2008 Dec; 283(51):35679-88. PubMed ID: 18936100
[TBL] [Abstract][Full Text] [Related]
66. The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis.
Rueckschloss U; Kuerten S; Ergün S
Histochem Cell Biol; 2016 Dec; 146(6):657-671. PubMed ID: 27695943
[TBL] [Abstract][Full Text] [Related]
67. CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium.
Zalzali H; Naudin C; Bastide P; Quittau-Prévostel C; Yaghi C; Poulat F; Jay P; Blache P
Oncogene; 2008 Nov; 27(56):7131-8. PubMed ID: 18794798
[TBL] [Abstract][Full Text] [Related]
68. CEACAM1 isoforms with different cytoplasmic domains show different localization, organization and adhesive properties in polarized epithelial cells.
Sundberg U; Obrink B
J Cell Sci; 2002 Mar; 115(Pt 6):1273-84. PubMed ID: 11884526
[TBL] [Abstract][Full Text] [Related]
69. Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells.
Singer BB; Scheffrahn I; Kammerer R; Suttorp N; Ergun S; Slevogt H
PLoS One; 2010 Jan; 5(1):e8747. PubMed ID: 20090913
[TBL] [Abstract][Full Text] [Related]
70. CEACAM1 inhibits cell-matrix adhesion and promotes cell migration through regulating the expression of N-cadherin.
Liu J; Di G; Wu CT; Hu X; Duan H
Biochem Biophys Res Commun; 2013 Jan; 430(2):598-603. PubMed ID: 23219815
[TBL] [Abstract][Full Text] [Related]
71. CEACAM1 is associated with recurrence after hepatectomy for colorectal liver metastasis.
Yamaguchi S; Yokoyama S; Ueno M; Hayami S; Mitani Y; Takeuchi A; Shively JE; Yamaue H
J Surg Res; 2017 Dec; 220():353-362. PubMed ID: 29180203
[TBL] [Abstract][Full Text] [Related]
72. Polymerase delta-interacting protein 38 (PDIP38) modulates the stability and activity of the mitochondrial AAA+ protease CLPXP.
Strack PR; Brodie EJ; Zhan H; Schuenemann VJ; Valente LJ; Saiyed T; Lowth BR; Angley LM; Perugini MA; Zeth K; Truscott KN; Dougan DA
Commun Biol; 2020 Nov; 3(1):646. PubMed ID: 33159171
[TBL] [Abstract][Full Text] [Related]
73. Direct interaction of tumor suppressor CEACAM1 with beta catenin: identification of key residues in the long cytoplasmic domain.
Jin L; Li Y; Chen CJ; Sherman MA; Le K; Shively JE
Exp Biol Med (Maywood); 2008 Jul; 233(7):849-59. PubMed ID: 18445773
[TBL] [Abstract][Full Text] [Related]
74. Vitamin D inhibits CEACAM1 to promote insulin/IGF-I receptor signaling without compromising anti-proliferative action.
Liu W; Guo M; Ezzat S; Asa SL
Lab Invest; 2011 Jan; 91(1):147-56. PubMed ID: 20714323
[TBL] [Abstract][Full Text] [Related]
75. The cell adhesion molecule CEACAM1-L is a substrate of caspase-3-mediated cleavage in apoptotic mouse intestinal cells.
Houde C; Roy S; Leung N; Nicholson DW; Beauchemin N
J Biol Chem; 2003 May; 278(19):16929-35. PubMed ID: 12637508
[TBL] [Abstract][Full Text] [Related]
76. CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.
Abou-Rjaily GA; Lee SJ; May D; Al-Share QY; Deangelis AM; Ruch RJ; Neumaier M; Kalthoff H; Lin SH; Najjar SM
J Clin Invest; 2004 Oct; 114(7):944-52. PubMed ID: 15467833
[TBL] [Abstract][Full Text] [Related]
77. Soluble isoforms of CEACAM1 containing the A2 domain: increased serum levels in patients with obstructive jaundice and differences in 3-fucosyl-N-acetyl-lactosamine moiety.
Dráberová L; Cerná H; Brodská H; Boubelík M; Watt SM; Stanners CP; Dráber P
Immunology; 2000 Oct; 101(2):279-87. PubMed ID: 11012782
[TBL] [Abstract][Full Text] [Related]
78. SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.
Ashkenazi S; Ortenberg R; Besser M; Schachter J; Markel G
Oncotarget; 2016 May; 7(21):30166-77. PubMed ID: 26885752
[TBL] [Abstract][Full Text] [Related]
79. Computational analysis of isoform-specific signal regulation by CEACAM1-A cell adhesion molecule expressed in PC12 cells.
Obrink B; Sawa H; Scheffrahn I; Singer BB; Sigmundsson K; Sundberg U; Heymann R; Beauchemin N; Weng G; Ram P; Iyengar R
Ann N Y Acad Sci; 2002 Oct; 971():597-607. PubMed ID: 12438192
[TBL] [Abstract][Full Text] [Related]
80. CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture.
Kirshner J; Chen CJ; Liu P; Huang J; Shively JE
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):521-6. PubMed ID: 12522268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
